Genomic sequencing is one of the best defenses against potentially deadlier or more transmissible variants of the coronavirus. It’s also expensive, slow, and currently almost nonexistent in the United States.
So some epidemiologists are advocating for an easier, cheaper, and faster way to help track variants’ paths through the country: a souped-up version of widely available Covid-19 diagnostic tests that can flag samples with any problematic genetic tweaks.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,